GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » 3-Year EPS without NRI Growth Rate

Winshine Science Co (HKSE:00209) 3-Year EPS without NRI Growth Rate : 38.00% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co 3-Year EPS without NRI Growth Rate?

Winshine Science Co's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.06.

During the past 3 years, the average EPS without NRI Growth Rate was 38.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 29.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Winshine Science Co was 60.10% per year. The lowest was -63.60% per year. And the median was 17.10% per year.


Competitive Comparison of Winshine Science Co's 3-Year EPS without NRI Growth Rate

For the Leisure subindustry, Winshine Science Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Winshine Science Co's 3-Year EPS without NRI Growth Rate Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Winshine Science Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Winshine Science Co's 3-Year EPS without NRI Growth Rate falls into.



Winshine Science Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Winshine Science Co  (HKSE:00209) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Winshine Science Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Winshine Science Co (HKSE:00209) Business Description

Traded in Other Exchanges
N/A
Address
287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG
Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.
Executives
Wang Honggang 2101 Beneficial owner
U Credit (hk) Limited 2106 Person having a security interest in shares
Csc Holdings Limited 2106 Person having a security interest in shares
Hurray Talent Investment Development Limited 2101 Beneficial owner
Li Zhonghai 2201 Interest of corporation controlled by you
Liu Lian 2201 Interest of corporation controlled by you
Richsun Investment Development Limited 2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited 2101 Beneficial owner
Jiang Qinghui 2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited") 2106 Person having a security interest in shares
China Strategic Holdings Limited 2106 Person having a security interest in shares
Shen Jia 2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines